RPHM — Reneo Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Reneo Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	24.9	53.6	148	101	103
Prepaid Expenses
Total Current Assets	25.4	55	154	106	107
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.079	0.069	0.212	1.75	0.733
Other Long Term Assets
Total Assets	25.5	55.2	154	108	107
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	2.94	4.58	6.2	7.12	18.2
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2.98	4.62	6.81	8.21	18.8
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	22.5	50.6	147	100	88.6
Total Liabilities & Shareholders' Equity	25.5	55.2	154	108	107
Total Common Shares Outstanding